Fate Therapeutics Inc. buy EF Hutton Acquisition Co. I
Start price
01.03.23
/
50%
€5.72
Target price
01.03.24
€9.37
Performance (%)
26.81%
End price
02.03.24
€7.25
Summary
This prediction ended on 02.03.24 with a price of €7.25. The prediction had a final performance of 26.81%. EF_Hutton_Acquisitio has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fate Therapeutics Inc. | 1.206% | 1.206% | 122.926% | -22.816% |
| iShares Core DAX® | 0.625% | 4.952% | 8.658% | 63.690% |
| iShares Nasdaq 100 | 1.160% | -1.160% | 26.817% | 89.860% |
| iShares Nikkei 225® | 2.356% | -1.354% | 48.195% | 81.683% |
| iShares S&P 500 | 0.631% | 1.380% | 22.985% | 70.248% |
Comments by EF_Hutton_Acquisitio for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its "buy" rating re-affirmed by analysts at EF Hutton Acquisition Co. I. They now have a $10.00 price target on the stock.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von EF_Hutton_Acquisitio gewählte maximale Laufzeit wurde überschritten